Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (931-940 of 1,161) with videos related to

Pageof 117
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2022
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomasP Selenica, A Marra, N J Choudhury, et al.
Cancer Medicine|December 4, 2024
Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young- and Average-Onset Gastric CancerPatrick T Magahis, Nicole Cornet, Laura Tang, et al.
Science (New York, N.Y.)|August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivityGopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
The Journal of Pathology|March 7, 2019
Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladderSumit Isharwal, Wenhuo Hu, Judy Sarungbam, et al.
Cancer Discovery|March 10, 2017
An Acquired <i>HER2</i><sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast CancerAriella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Neurology|May 30, 2002
A multicenter study of treatment of primary CNS lymphomaA J M Ferreri, M Reni, F Pasini, et al.
Endocrine Pathology|September 22, 2021
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical CarcinomasSounak Gupta, Helen Won, Kalyani Chadalavada, et al.
Leukemia|November 6, 2010
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitroJ Iqbal, D D Weisenburger, A Chowdhury, et al.
Pageof 117

Showing results (931-940 of 1,161) with videos related to

Sort By:
Pageof 117
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2022
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomasP Selenica, A Marra, N J Choudhury, et al.
Cancer Medicine|December 4, 2024
Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young- and Average-Onset Gastric CancerPatrick T Magahis, Nicole Cornet, Laura Tang, et al.
Science (New York, N.Y.)|August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivityGopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
The Journal of Pathology|March 7, 2019
Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladderSumit Isharwal, Wenhuo Hu, Judy Sarungbam, et al.
Cancer Discovery|March 10, 2017
An Acquired <i>HER2</i><sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast CancerAriella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Neurology|May 30, 2002
A multicenter study of treatment of primary CNS lymphomaA J M Ferreri, M Reni, F Pasini, et al.
Endocrine Pathology|September 22, 2021
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical CarcinomasSounak Gupta, Helen Won, Kalyani Chadalavada, et al.
Leukemia|November 6, 2010
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitroJ Iqbal, D D Weisenburger, A Chowdhury, et al.
Pageof 117